An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase (vol 143, pg 2059, 2017)

Luis Steegmann Juan; Colomer Dolors; Gomez-Casares Maria-Teresa; Garcia-Gutierrez Valentin; Orti Guillermo; Ramirez-Payer Angel; Olavarria Eduardo; Vall-llovera Ferran; Giraldo Pilar; Conde Eulogio; Vallansot Rolando; Luis Lopez-Lorenzo Jose; Palomera Luis; Alvarez-Larran Alberto; Conesa Venancio; Bautista Guiomar; Casas Laura; Giles Frank; Hochhaus Andreas; Felipe Casado-Montero Luis

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase (vol 143, pg 2059, 2017)

【24h】

An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase (vol 143, pg 2059, 2017)

机译：新诊断慢性核糖细胞核白血病患者核苷酸治疗前三个月治疗期间分子反应动力学分析（Vol 143，PG 2059,2017）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Correction to: J Cancer Res Clin Oncol (2017) 143:2059-2066 DOI 10.1007/s00432-017-2445-z.

机译：校正至：J Cancer Res Clin Col（2017）143：2059-2066 DOI 10.1007 / S00432-017-2445-Z。

著录项

来源
《Journal of Cancer Research and Clinical Oncology》 |2018年第1期|共2页
作者
Luis Steegmann Juan; Colomer Dolors; Gomez-Casares Maria-Teresa; Garcia-Gutierrez Valentin; Orti Guillermo; Ramirez-Payer Angel; Olavarria Eduardo; Vall-llovera Ferran; Giraldo Pilar; Conde Eulogio; Vallansot Rolando; Luis Lopez-Lorenzo Jose; Palomera Luis; Alvarez-Larran Alberto; Conesa Venancio; Bautista Guiomar; Casas Laura; Giles Frank; Hochhaus Andreas; Felipe Casado-Montero Luis;
展开▼
作者单位

Hosp Princesa Hematol Serv Adv Therapies Oncohematol IIS IP Madrid Spain;

Hosp Clin Barcelona Unitat Hematopatol Barcelona Spain;

Hosp Univ Gran Canaria Dr Negrin Lab Hematol Biol Mol Las Palmas Gran Canaria Spain;

Hosp Univ Ramon y Cajal Serv Hematol IRYCIS Madrid Spain;

Hosp Univ Vall dHebron Dept Hematol VHIO Barcelona Spain;

Hosp Univ Cent Asturias Serv Hematol Oviedo Spain;

Imperial Coll Healthcare NHS Trust Dept Hematol London England;

Hosp Univ Mutua Terrassa Serv Hematol Terrassa Spain;

IIS Aragon CIBERER Zaragoza Spain;

Univ Cantabria Hematol Santander Spain;

Hosp Univ Joan XXIII ICO Tarragona Serv Hematol Tarragona Spain;

Clin Concepcion Hematol Madrid Spain;

Hosp Clin Univ Lozano Blesa Inst Invest ISS Aragon Zaragoza Spain;

Hosp del Mar Dept Hematol IMIM Barcelona Spain;

Hosp Gen Dept Salut Elx Hematol Elche Spain;

Hosp Puerta de Hierro Hematol Madrid Spain;

Dynam Solut SL Dept Stat Barcelona Spain;

Northwestern Univ Feinberg Sch Med Div Hematol Oncol Chicago IL 60611 USA;

Univ Klinikum Jena Klin Innere Med Hamatol Onkol 2 Jena Germany;

Hosp Virgen de la Salud Serv Hematol &

Hemoterapia Toledo Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase (vol 143, pg 2059, 2017) [J] . Luis Steegmann Juan, Colomer Dolors, Gomez-Casares Maria-Teresa, Journal of Cancer Research and Clinical Oncology . 2018,第1期

机译：新诊断慢性核糖细胞核白血病患者核苷酸治疗前三个月治疗期间分子反应动力学分析（Vol 143，PG 2059,2017）
2. Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR4.5): The phase 2, multicenter N‐Road study [J] . Kaichi Nishiwaki, Kei‐ji Sugimoto, Shigehisa Tamaki, Cancer Medicine . 2020,第11期

机译：基于深度分子响应的早期成果的新诊断慢性相慢性骨髓白血病患者的最佳治疗策略（MR4.5）：2，多中心N-道路研究
3. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Retraction of Vol 17, Pg 1851, 2016) [J] . Saydam Guray, Haznedaroglu Ibrahim C., Kaynar Leylagul, Hematology. . 2018,第9期

机译：与前线尼洛替尼治疗的结果在土耳其患者治疗新诊断的费城染色体阳性慢性骨髓性白血病（慢性阶段）（卷17，PG 1851,2016）
4. A new FISH Signals Fusion Detection approach for diagnosing Chronic Myeloid Leukemia [C] . Ashraf AbdelRaouf International Conference on Computer Engineering and Systems . 2019

机译：一种新的FISH信号融合检测方法，用于诊断慢性粒细胞白血病
5. Influences on physician recommendation for imatinib mesylate in chronic phase chronic myeloid leukemia patients. [D] . Iyer, Shrividya Sethuraman. 2003

机译：对慢性期慢性粒细胞白血病患者甲磺酸伊马替尼的医师推荐的影响。
6. Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase [O] . Juan Luis Steegmann, Dolors Colomer, Maria-Teresa Gómez-Casares, -1

机译：更正为：对新诊断的慢性粒细胞白血病慢性期患者使用尼洛替尼治疗的前三个月分子反应的动力学分析
7. Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR 4.5 ): The phase 2, multicenter N‐Road study [O] . Kaichi Nishiwaki, Kei‐ji Sugimoto, Shigehisa Tamaki, 2020

机译：基于深度分子响应的早期成果的新诊断慢性阶段慢性骨髓白血病患者的最佳治疗策略（4.5先生）：2，Multiger N-Road研究

An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase (vol 143, pg 2059, 2017)

摘要

著录项

相似文献

相关主题

期刊订阅